Prague Med. Rep. 2023, 124, 444-448

https://doi.org/10.14712/23362936.2023.34

Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient

Eliška Dvořáčková1, Andrea Zajacová2, Jan Havlín3, Eva Klapková4, Robert Lischke3, Ondřej Slanař1, Martin Šíma1

1Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
2Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
3Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
4Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

Received August 23, 2023
Accepted November 15, 2023

Crossref Cited-by Linking

  • Tan Zhaoyi, Zhang Na, Liang Beibei, Bai Nan, Cai Yun: Therapeutic drug monitoring of isavuconazole: Trends and update. International Journal of Antimicrobial Agents 2025, 66, 107619. <https://doi.org/10.1016/j.ijantimicag.2025.107619>
  • Silva Jose Tiago, Solé Amparo, Aguado José María: Real-life experience on the use of isavuconazole in solid organ transplantation. Revista Iberoamericana de Micología 2025, 42, 26. <https://doi.org/10.1016/j.riam.2025.02.004>
  • Zhao Tingting, Fang Yuan, Wu Qiuhui, Shi Minke, Ni Yueyan, Zou Ruyi, Liu Mengying, Wu Weiwei, Su Xin: Successful Treatment of Mucormycosis and Azole-Resistant Aspergillus Coinfection in a Diabetic Patient: A Case Report. IDR 2025, Volume 18, 3689. <https://doi.org/10.2147/IDR.S530615>
Crossref Cited-by Linking logo